Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients
UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).
UCSF bioengineer Tejal Desai, PhD, will receive the 2012 Paul R. Dawson Biotechnology Award from the American Association of Colleges of Pharmacy (AACP) at the group’s annual meeting in July.
Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.
In the first symposium held by the newly minted UCSF Department of Bioengineering and Therapeutic Sciences, researchers described progress in the fields of systems biology, pharmacogenomics, and bioengineering, and how scientists in these fields are working in concert to develop novel diagnostics...
UCSF scientists describe how their research is aiming to make therapeutics sophisticated, highly effective, and tailored to the different needs of individuals.